Long-term follow-up of normal peripheral blood progenitor cell donors treated with filgrastim: No evidence of increased risk of leukemia development

P. Anderlini, F. A. Chan, R. E. Champlin, M. Körbling, S. S. Strom

Research output: Contribution to journal › Article › peer-review

51 Scopus citations

Fingerprint

Dive into the research topics of 'Long-term follow-up of normal peripheral blood progenitor cell donors treated with filgrastim: No evidence of increased risk of leukemia development'. Together they form a unique fingerprint.

Medicine & Life Sciences